» Articles » PMID: 18782399

Emerging Viral Threats to the Australian Blood Supply

Overview
Publisher Elsevier
Specialty Public Health
Date 2008 Sep 11
PMID 18782399
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess the risk to the Australian blood supply posed by emerging or re-emerging viral infections.

Method: A review was undertaken of the English-speaking literature on the potential for emerging viral threats to human health in Australia, the future implications of virus ecology, climate change and population movement and the implications for blood transfusion.

Results: Published data confirm that Australia's blood supply is among the safest in the world for currently screened viral pathogens as a result of rigorous surveillance, donor selection and state-of-the-art processing and laboratory testing. However, Australia has a number of other viral pathogens with the potential to threaten the safety of the blood supply such as the Ross River, Barmah Forrest, Kunjin, Japanese Encephalitis, Murray Valley Encephalitis and dengue viruses. Of these, dengue is currently of most concern to blood safety because; it can cause fatalities, there are regular seasonal outbreaks in Northern Australia and, in contrast to other viruses mentioned above an overseas case of transfusion transmission has already been documented. Notably, despite the lack of a suitable dengue screening test the ARCBS already implements supplementary measures to protect the blood supply during outbreaks.

Conclusion: Current interventions have proven extremely effective in minimising transfusion transmission in Australia of recognised viral pathogens. The threat posed by emerging viral pathogens to the safety of blood transfusion emphasises the need for global collaboration and consideration of further intervention strategies on a country by country basis including options such as nucleic acid testing and pathogen reduction technologies.

Citing Articles

Evidence of Infection with Zoonotic Mosquito-Borne Flaviviruses in Saltwater Crocodiles () in Northern Australia.

Habarugira G, Moran J, Harrison J, Isberg S, Hobson-Peters J, Hall R Viruses. 2022; 14(5).

PMID: 35632847 PMC: 9144604. DOI: 10.3390/v14051106.


Wolbachia strain wAlbB blocks replication of flaviviruses and alphaviruses in mosquito cell culture.

Ekwudu O, Devine G, Aaskov J, Frentiu F Parasit Vectors. 2020; 13(1):54.

PMID: 32041638 PMC: 7011541. DOI: 10.1186/s13071-020-3936-3.


Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.

Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, Muller T Vox Sang. 2020; 115(3):146-151.

PMID: 31930543 PMC: 7169309. DOI: 10.1111/vox.12888.


Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, China.

Cheng V, Sridhar S, Wong S, Wong S, Chan J, Yip C Emerg Infect Dis. 2017; 24(1).

PMID: 29043965 PMC: 5749455. DOI: 10.3201/eid2401.171297.


Pathogen inactivation technologies for cellular blood components: an update.

Schlenke P Transfus Med Hemother. 2014; 41(4):309-25.

PMID: 25254027 PMC: 4164100. DOI: 10.1159/000365646.


References
1.
Mison L, Seed C, Margaritis A, Hyland C . Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang. 2003; 84(1):11-9. DOI: 10.1046/j.1423-0410.2003.00246.x. View

2.
Ligon B . Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention. Semin Pediatr Infect Dis. 2005; 16(1):60-5. DOI: 10.1053/j.spid.2004.09.013. View

3.
Klein H, Anderson D, Bernardi M, Cable R, Carey W, Hoch J . Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference. Vox Sang. 2007; 93(2):179-82. DOI: 10.1111/j.1423-0410.2007.00937.x. View

4.
Bihl F, Castelli D, Marincola F, Dodd R, Brander C . Transfusion-transmitted infections. J Transl Med. 2007; 5:25. PMC: 1904179. DOI: 10.1186/1479-5876-5-25. View

5.
Burnouf T, Radosevich M . Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev. 2000; 14(2):94-110. DOI: 10.1054/blre.2000.0129. View